| Akums Drugs & Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 544222 |
NSE Symbol : AKUMS |
P/E(TTM) : 48.90 |
|
ISIN Demat : INE09XN01023 |
Div & Yield% : 0.00 |
EPS(TTM) : 8.71 |
|
Book Value(₹) : 150.82 |
Market Cap(₹Cr) : 6,703.41 |
Face Value(₹) : 2.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,311.78 | 1,444.12 | 1,286.83 | 1,162.06 | 837.44 |
| Other Income | 128.06 | 94.12 | 96.15 | 58.48 | 54.51 |
| Stock Adjustments | 10.05 | -6.44 | 3.06 | 18.45 | -10.64 |
| Total Income | 1,449.89 | 1,531.80 | 1,386.04 | 1,238.99 | 881.31 |
| EXPENDITURE : | |||||
| Raw Materials | 811.06 | 867.24 | 791.21 | 786.51 | 513.05 |
| Power and Fuel Cost | 45.36 | 42.40 | 42.04 | 36.25 | 28.64 |
| Other Manufacturing Expenses | 68.18 | 62.69 | 42.04 | 62.62 | 51.89 |
| Selling and Administration Expenses | 23.27 | 31.90 | 22.33 | 16.82 | 13.80 |
| Miscellaneous Expenses | 37.60 | 404.21 | 147.63 | 503.99 | 319.56 |
| Employee Benefit Expenses | 201.74 | 175.28 | 147.30 | 136.37 | 122.65 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 262.69 | -51.93 | 193.50 | -303.56 | -168.28 |
| Interest | 15.31 | 18.31 | 13.18 | 3.65 | 0.82 |
| Gross Profit | 247.38 | -70.24 | 180.32 | -307.21 | -169.10 |
| Depreciation | 39.55 | 32.69 | 30.00 | 27.76 | 26.10 |
| Profit Before Tax | 207.83 | -102.93 | 150.32 | -334.97 | -195.20 |
| Current Tax | 46.84 | 62.52 | 41.00 | 0.34 | 6.40 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | -16.11 | 46.46 | -56.17 |
| Reported Net Profit | 161.00 | -165.45 | 125.43 | -381.78 | -145.43 |
| Extraordinary Items | -0.04 | -7.98 | -105.11 | 0.99 | -255.75 |
| Adjusted Net Profit | 161.04 | -157.47 | 230.54 | -382.77 | 110.32 |
| Adjustment below Net Profit | 861.44 | -2.18 | 0.00 | -11.62 | 0.16 |
| Profit/Loss Balance carried down | 295.39 | 463.02 | 351.36 | 744.75 | 890.02 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 13.77 | 0.00 | 0.00 |
| P & L Balance carried down | 1,317.83 | 295.39 | 463.02 | 351.36 | 744.75 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 10.52 | -11.56 | 8.77 | -53.37 | -1,117.82 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 150.57 | 10.06 | 21.77 | 25.94 | 4,358.55 |
| Book Value(Adj)-Unit Curr | 150.57 | - | - | - | - |